Developing New Approaches to Clinical Data & Evidence Generation to Demonstrate Initial Benefit & Support Long Term Follow Up
15:30pm Chair Introduction
To be Confirmed
15:35pm Presentation: Title to be Confirmed
- Bulletpoint 1
- Bulletpoint 2
- Bulletpoint 3
Michael Von Forstner, Senior Medical Director, Global Head of Patient Safety and Pharmacovigilance, Biosimilars, Biogen
15:50pm Presentation: Title to be Confirmed
- Bulletpoint 1
- Bulletpoint 2
- Bulletpoint 3
Senior Representative, Title21
16:05 Presentation: Title to be Confirmed
- Bulletpoint 1
- Bulletpoint 2
- Bulletpoint 3
Presenter to be Confirmed
16:20pm Presentation: Title to be Confirmed
- Bulletpoint 1
- Bulletpoint 2
- Bulletpoint 3
Presenter to be Confirmed
16:35pm Closing Panel with Q&A
With all session participants
Speakers
Michael von Forstner
Senior Medical Director, Global Head of Patient Safety and Pharmacovigilance, Biosimilars